Agilon Health (NYSE:AGL) Shares Gap Down – Time to Sell?

Agilon Health, Inc. (NYSE:AGL) gapped down prior to trading on Tuesday . The stock had previously closed at $92.54, but opened at $86.85. Agilon Health shares last traded at $89.06, with a volume of 8,165 shares.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on AGL shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a report on Monday, August 24th. Wells Fargo & Company reiterated an “overweight” rating and issued a $146.00 target price (up from $141.00) on shares of Agilon Health in a report on Tuesday, August 11th. Robert W. Baird set a $116.00 price target on Agilon Health in a research note on Thursday, August 6th. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $33.00 to $49.00 in a report on Thursday, May 7th. Finally, Citigroup raised shares of Agilon Health from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $105.00 to $115.00 in a research note on Monday, August 10th. Five analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $97.70.

Agilon Health Trading Down 0.1%

The company’s 50-day simple moving average is $103.62 and its 200 day simple moving average is $64.44. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $1.47 billion, a PE ratio of -6.15 and a beta of 3.01.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.45 billion. As a group, sell-side analysts expect that Agilon Health, Inc. will post -2.33 EPS for the current year.

Institutional Trading of Agilon Health

A number of institutional investors have recently made changes to their positions in the business. Rubicon Founders LLC purchased a new stake in Agilon Health in the second quarter valued at about $11,290,448. Great Lakes Advisors LLC acquired a new stake in Agilon Health in the second quarter worth about $702,000. Alpine Global Management LLC purchased a new stake in shares of Agilon Health during the fourth quarter worth about $84,000. Corient Private Wealth LP purchased a new stake in shares of Agilon Health during the second quarter worth about $406,000. Finally, California State Teachers Retirement System acquired a new position in shares of Agilon Health during the second quarter valued at about $1,976,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.